Press Release Details

Program Demonstrates Company's Commitment to Corporate Citizenship

MELVILLE, N.Y.--(BUSINESS WIRE)--Oct. 1, 2024-- Henry Schein, Inc. (Nasdaq: HSIC) today announced the annual launch of its 2024 Practice Pink® program, a global initiative that has donated more than $2 million over the past 18 years to help create awareness and support for the campaign against cancer. The program is an initiative of Henry Schein Cares, the Company’s global corporate citizenship program.

Through the Practice Pink program, Henry Schein, together with non-governmental organizations and supplier partners across North America and Europe, assists dental and medical health care professionals in raising awareness and support to help find a cure for cancer. By offering its customers a variety of pink products, including health care consumables, practice supplies, and apparel, the Practice Pink program supports important cancer research and prevention efforts.

“As we kick off another year helping to support cancer patients and their families, Henry Schein looks forward to working with supplier partners and customers whose shared values help make the Practice Pink program a success,” said Maureen Knott, Vice President of U.S. Supplier Initiatives, Henry Schein, and President of the Henry Schein Cares Foundation. “Thanks to our public-private partnerships, we can help advance cancer research and prevention while providing comfort to those impacted by cancer. Together, we can help health happen.”

The Practice Pink program supports U.S.-based organizations, including the American Cancer Society. The program also supports various organizations in Europe, including ALADINA, KiKa, LILT, Odyssea, and others.

For more information about Henry Schein’s Practice Pink program and Henry Schein Cares, please visit www.henryschein.com/PracticePink. For oral health professionals looking to purchase pink dental products, click here. For medical professionals looking to purchase pink products, click here.

About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.3 billion in 2023 and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240930941463/en/

Ann Marie Gothard
Vice President, Global Corporate Media Relations
annmarie.gothard@henryschein.com
(631) 390-8169

Source: Henry Schein, Inc.